Ascendis Pharma A/S to Participate in 40th Annual J.P. Morgan Healthcare Conference

NEXT STORY
AVEO Oncology Highlights Recent Progress and 2022 Outlook
PREV STORY
Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Idorsia to debut at the 39th J.P. Morgan Healthcare Conference – Major catalysts expected in the near-term – Daridorexant NDA submitted to the US FDA

author_avatar
NASDAQ Market News

Results of Single Center Study on Delcath’s PHP Therapy Published in Cancer Imaging

author_avatar
NASDAQ Market News

Contract Research Organization Market Size and Share at 11.48% CAGR Expected by 2023 | Global CRO Market Trend and Demand in Healthcare Sector

The Global Contract Research Organization (CRO) Market can expand owing to prevalence of various ...

author_avatar
NASDAQ Market News